fatty15 Review

What fatty15 actually is — and why it's on a weight-loss list

Let's be clear up front: fatty15 is not a weight-loss drug, a telehealth clinic, or a GLP-1 prescriber. It's a single-ingredient daily supplement built around C15:0 (pentadecanoic acid), an odd-chain saturated fatty acid you mostly get from whole dairy fat. It's made by Seraphina Therapeutics, a San Diego company that has marketed C15:0 hard as a longevity and 'cellular health' nutrient. We list it here because it sits in the metabolic-health conversation — inflammation, cell-membrane stability, liver and metabolic markers — that overlaps with weight management, not because taking it will move the scale. If you came looking for something that causes weight loss, this isn't it, and we'd rather say that plainly than dress it up.

The C15:0 pitch, separated from the marketing

The real, verifiable part of the story is solid for a supplement. C15:0 earned GRAS status (Generally Recognized as Safe) from the FDA in 2021, which you can confirm in the agency's own GRAS notice inventory. There's peer-reviewed research behind the molecule, including published work on pentadecanoic acid's effects on cellular aging and a 2024 nutrition RCT in people with overweight or obesity. The mechanism the company describes — C15:0 incorporating into cell membranes and supporting mitochondrial function — is a genuine, plausible biological story, not pure hand-waving. And because C15:0 is hard to get from diet unless you eat a fair amount of full-fat dairy, the case for supplementing it is at least defensible.

What you should treat with skepticism is the headline framing. fatty15's signature claim — that C15:0 is the 'first essential fatty acid discovered in 90-plus years' — is company positioning, not scientific consensus. C15:0 has not met the formal IOM/NIH criteria for being classified as an 'essential' fatty acid. That's a meaningful distinction: 'essential' is a regulatory and nutritional term with a specific bar, and a brand calling its own ingredient essential is marketing. The science is interesting and early; the label is louder than the evidence.

How the pricing works

fatty15 doesn't have a 'monthly prescription price' in the way the GLP-1 providers on this site do, so we don't publish a standard monthly rate for it — confirm current pricing on the brand's own site before you buy. In practice it's sold as a starter kit covering roughly a three-month supply, with a regular price in the low three figures and a promotional first-kit price somewhat below that, which works out to roughly forty to fifty dollars a month at the regular rate. It runs on a subscription model, so the meaningful question isn't the sticker — it's whether you'll keep paying that every month indefinitely, because a longevity supplement only 'works' as a daily habit, not a one-time buy.

What you're getting in the bottle

• A single active ingredient: C15:0 (pentadecanoic acid), in vegan capsules — no stimulants, no appetite suppressants, no proprietary blend hiding the dose.
• A daily-habit product, not a course of treatment — the proposed benefits are about long-term cellular and metabolic health, not a measurable short-term result.
• No prescription, no consult, no telehealth visit — you buy it like any other supplement, which also means no clinician is reviewing your health history.

What genuinely sets it apart

Most supplements in this space are kitchen-sink blends with a dozen under-dosed ingredients and zero original research. fatty15's real differentiator is the opposite: one molecule, a clear mechanism, FDA GRAS status, and a published research portfolio the company actually generated. It was also named the #1 fastest-growing supplement company on the 2025 Inc. 5000 list, which tells you the marketing is working — but growth and brand recognition are not the same thing as proven outcomes. The honest read is that fatty15 is unusually disciplined for a supplement and unusually aggressive in how it frames the science.

Who should consider it — and who should skip it

This makes sense for someone who is already eating well and exercising, has the budget for an ongoing supplement, and wants a single-ingredient bet on long-term cellular and metabolic health with a real mechanism behind it. It's a reasonable 'I've covered the basics, what's next' purchase for the longevity-curious.

Skip it if you're hoping it will help you lose weight — there's no good evidence it does that, and anyone implying otherwise is overselling. Skip it if money is tight, because the daily-forever subscription adds up and the upside is incremental, not dramatic. And skip it if you have an actual metabolic condition you're trying to treat: a supplement is not a substitute for a semaglutide or tirzepatide program supervised by a prescriber, and fatty15 itself isn't claiming to be.

Trust, safety, and how confident we are

On the trust side, fatty15 scores better than most supplements. The legal entity (Seraphina Therapeutics Inc.) is verifiable, the FDA GRAS status is real, the published research exists, and we found no FDA warning letters and no FTC enforcement actions on file. There's no compounding partner or controlled medication involved, so the safety profile is that of a food-grade fatty acid. Our remaining reservations are about the claims, not the company: the longevity benefits are early-stage, the 'essential fatty acid' framing is unsettled, and the ingredient panel and third-party lab testing still deserve independent verification rather than taking the brand's word for it. We've rated our confidence at a medium level on that basis — see our scoring methodology for how that's weighted.

The bottom line

fatty15 is one of the more credible single-ingredient supplements you can buy, with a real molecule, a clear mechanism, GRAS status, and published research — wrapped in marketing that runs ahead of the evidence. As a longevity and cellular-health play for people who've already nailed diet and exercise, it's a defensible, if optional, purchase. As a weight-loss product, it isn't one, and we won't pretend it is. Buy it for what it actually is: an early, plausible bet on C15:0, not a metabolic shortcut.